Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)

Clinical trial NCT04931563 · COMPLETED

Trial details

NCT number: NCT04931563
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Active Systemic Lupus Erythematosus

Start date: 2021-09-13
Primary completion: 2025-04-07
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.